• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Agitated Solutions wins CE mark for cardiac microbubble generator device

Agitated Solutions wins CE mark for cardiac microbubble generator device

May 1, 2026 By Sean Whooley

Agitated Solutions Orbis microbubble generator
The Orbis microbubble generator device [Image courtesy of Agitated Solutions]
Agitated Solutions announced that it received CE mark approval for its novel Orbis microbubble generator device.

St. Paul, Minnesota-based Agitated Solutions designed Orbis to streamline agitated saline contrast generation and enhance bubble quality. It helps to deliver consistent, clear and bright ultrasound images and more efficient workflows.

Initially, the company targets saline contrast echocardiography studies (known as “bubble studies”) as the market for Orbis. The studies currently serve as the standard of care for diagnosing right-to-left cardiac shunts, which cause improper blood flow. These can also be a leading cause of stroke, particularly in young people.

According to a news release, approximately a quarter of the adult population has right-to-left shunts. Millions of bubble studies take place globally each year. In these studies, investigators manually mix saline with air to produce microbubbles for implantation. Manual production means bubble consistency can vary, impacting diagnosis. The studies also require one clinician to agitate and inject the saline while a second captures the images, making them resource-intensive and time-consuming.

Orbis products controlled microbubble sizes and concentrations. It can help to improve image quality and facilitate diagnosis of right-to-left cardiac shunts. The technology also requires just one sonographer to administer bubbles as well.

Agitated Solutions currently has a U.S. study underway to support a future FDA submission. It also offers the Orbis device in Canada.

Commentary from Agitated Solutions officials

Morgan Evans, co-founder and CEO of Agitated Solutions, said:

“The CE Mark approval underscores the strength of our innovation and its potential to redefine the standard for saline microbubble contrast. We are excited to bring this solution to European clinicians, helping to improve consistency, streamlining procedures, and enhancing diagnostic confidence.”

Dr. Micah Eimber, chief medical officer of Agitated Solutions, said:

“Bubble studies have been conducted with manual agitation for around 60 years. The lack of consistency impacts the ability to accurately diagnose and treat patients. The Orbis™ Microbubble Generator is a major advancement towards providing clinicians a more consistent contrast and image quality, and facilitating downstream care.”

 

Agitated Solutions was one of Medical Design & Outsourcing’s 10 Minnesota medtech startups you need to know in 2021. Read more here.

Filed Under: Cardiovascular, Imaging, Regulatory/Compliance, Ultrasound Tagged With: Agitated Solutions

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy